Weight-Loss Drug Stocks Fall Below Critical Levels
📊 LLY — Piyasa Yorumu
▼ down · 65%The headline notes that stocks in the weight-loss drug sector have fallen below critical support levels, creating negative sentiment for LLY. Technical indicators support this view: while the RSI at 32.96 approaches oversold territory, the MACD is negative and below its signal line, indicating a loss of momentum. The price is trading below both the 20-day and 50-day moving averages, with a sharp decline of 6.8% over the last 24 hours. In the short term, there is a high risk of continued selling pressure, though some bargain buying may emerge due to oversold conditions. Therefore, while the direction is bearish, the confidence level is maintained at moderate.
📊 NVO — Piyasa Yorumu
▼ down · 65%The headline notes that stocks in the weight-loss drug sector have fallen below critical support levels, creating negative sentiment for NVO. Technical indicators support this view: RSI is in oversold territory at 26.6, MACD is below the signal line, and the price is below both the 20-day and 50-day moving averages. The sharp 7.8% decline over the last 24 hours indicates continued selling pressure. While a short-term rebound is possible, the current momentum is downward, suggesting the decline may persist. However, given oversold conditions, some technical bounce could occur, so I maintain a medium-high confidence level.